Architecting autonomy: A design pattern for high-compute, governed agents in biotech

In production systems today, most AI agents operate as lightweight dispatchers. They parse a prompt, make an API call, retrieve a record, and hand back control. Their execution is fast, stateless and cheap. Biotechnology does not work this way.  Folding a protein target, screening a 50,000 compound

Read the full article: Architecting autonomy: A design pattern for high-compute, governed agents in biotech